Name | Cinsebrutinib |
---|
Description | Cinsebrutinib is a Bruton's tyrosine kinase inhibitor, extracted from patent WO2021207549 (compound 5-6). Cinsebrutinib has the potential for cancer study. |
---|---|
Related Catalog | |
References |
Molecular Formula | C22H26FN3O2 |
---|---|
Molecular Weight | 383.46 |